09-Nov-2021 | Zion Market Research
As per the findings of Zion Market Research study, Immuno-Oncology Clinical Trials industry gathered revenue about US$ 5.4 billion in 2020 and is slated to earn revenue of approximately US$ 15.6 billion by 2028. Moreover, Immuno-Oncology Clinical Trials market is expected to record highest gains of about 13.7% in 2021-2028. Apparently, expansion of immuno-oncology clinical trials market over forecast timespan can be credited to increase in cases of cancer along with need for targeted drug treatment for oncology. In addition to this, rise in biomarker & checkpoint inhibitor studies will prominently boost immuno-oncology clinical trials in coming years. Moreover, thriving pharmaceutical sector and increase in stem cell research activities as well as genome research activities will prompt growth of immuno-oncology clinical trials market in upcoming years. Furthermore, introduction of new cancer drug treatments will generate new growth avenues for immuno-oncology clinical trials industry over ensuing years.
Interventional Trials To Lead Design Segment Over 2021-2028
Growth of interventional trials segment over forecast timeframe is owing to large number of interventional clinical trials used for measuring effectiveness of drug treatments for cancer during clinical trial phase. In addition to this, interventional trials are used for exhibiting the efficacy of some of medical treatments in present state of the disease along with forecasting its proficiency in treating later or advanced stage of cancer.
Solid Tumors Segment To Capture Major Share of Immuno Oncology Clinical Trials Market Over 2021-2028
Solid tumor segment is predicted to have deep influence on expansion of immuno oncology clinical trials market over coming years. The growth of the segment and its impact on business can be credited to massive government focus on developing new cancer therapies for treating these solid tumors which occur in muscle tissues, organ tissues, and cell tissues.
Asia Pacific Immuno Oncology Clinical Trials Market To Record Fastest Growth Over 2021-2028
Remarkable expansion of Immuno Oncology Clinical Trials Market in Asia Pacific zone over anticipated period can be ascribed to a prominent rise in biotech firms in Asia & Australia with favorable government policies on FDI in regions such as Asia. Apart from this, increase in number of immuno oncology clinical trials carried out in countries such as India and China will proliferate size of regional market in upcoming timespan.
Key players leveraging growth of immuno oncology clinical trials industry and profiled in report are Novartis AG, Medpace Holdings, Inc., Syneous Health, AstraZeneca plc, and Exscientia.
Browse the full “Immuno-Oncology Clinical Trials Market- By Design (Interventional Trials And Observational Trials), By Phase (Phase I, Phase II, Phase III, And Phase IV), By Indication (Solid Tumors And Hematological Cancer), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2028.” Report at https://www.zionmarketresearch.com/report/immuno-oncology-clinical-trials-market
The global Immuno-Oncology Clinical Trials Market is segmented as follows:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651